UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 254

Sortiert nach

Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2013-02, Vol.31 (6), p.794-810

2013

Link zum Volltext

Verfügbarkeit prüfen

Neutropenic Enterocolitis, a Growing Concern in the Era of Widespread Use of Aggressive Chemotherapy

Clinical infectious diseases, 2013-03, Vol.56 (5), p.711-717

2013

Link zum Volltext

Verfügbarkeit prüfen

The current spectrum of infection in cancer patients with chemotherapy related neutropenia

Infection, 2014-02, Vol.42 (1), p.5-13

2014

Link zum Volltext

Verfügbarkeit prüfen

Activity of Cefiderocol and Comparators against Isolates from Cancer Patients

Antimicrobial agents and chemotherapy, 2020-04, Vol.64 (5)

2020

Link zum Volltext

Verfügbarkeit prüfen

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

Antimicrobial agents and chemotherapy, 2019-07, Vol.63 (7)

2019

Link zum Volltext

Verfügbarkeit prüfen

Administering an additional hepatitis B vaccination dose after 18 years maintains adequate long-term protection levels in healthcare workers

Infectious diseases (London, England), 2020-05, Vol.52 (5), p.330-335

2020

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update

Journal of clinical oncology, 2018-10, Vol.36 (30), p.3043-3054

2018

Link zum Volltext

Verfügbarkeit prüfen

Postobstructive Pneumonia in Cancer Patients

Clinical infectious diseases, 2016-09, Vol.63 (5), p.707-708

Rolston, Kenneth V.

2016

Link zum Volltext

Verfügbarkeit prüfen

2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

Clinical infectious diseases, 2002-03, Vol.34 (6), p.730-751

2002

Link zum Volltext

Verfügbarkeit prüfen

Polymicrobial Infection in Patients with Cancer: An Underappreciated and Underreported Entity

Clinical infectious diseases, 2007-07, Vol.45 (2), p.228-233

2007

Link zum Volltext

Verfügbarkeit prüfen

The impact of incorporating early rapid influenza diagnosis on hospital occupancy and hospital acquired influenza

Infection control and hospital epidemiology, 2019-08, Vol.40 (8), p.897-903

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

Clinical infectious diseases, 2011-02, Vol.52 (4), p.e56-e93

2011

Link zum Volltext

Verfügbarkeit prüfen

Stenotrophomonas maltophilia: Changing Spectrum of a Serious Bacterial Pathogen in Patients with Cancer

Clinical infectious diseases, 2007-12, Vol.45 (12), p.1602-1609

2007

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of a Clinical Model to Predict the Presence of β-Lactam Resistance in Viridans Group Streptococci Causing Bacteremia in Neutropenic Cancer Patients

Clinical infectious diseases, 2014-07, Vol.59 (2), p.223-230

2014

Link zum Volltext

Verfügbarkeit prüfen

The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC “Neutropenia, Infection and Myelosuppression” Study Group during the MASCC annual meeting held in Berlin on 27–29 June 2013

Supportive care in cancer, 2016-07, Vol.24 (7), p.2819-2826

2016

Link zum Volltext

Verfügbarkeit prüfen

Viridans Streptococci Isolated by Culture from Blood of Cancer Patients: Clinical and Microbiologic Analysis of 50 Cases

Journal of Clinical Microbiology, 2006, Vol.44 (1), p.160-165

2006

Link zum Volltext

Verfügbarkeit prüfen

Daptomycin use in neutropenic patients with documented gram-positive infections

Supportive care in cancer, 2014, Vol.22 (1), p.7-14

2014

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of ceftaroline and comparator agents against Gram-positive and Gram-negative clinical isolates from cancer patients

International journal of antimicrobial agents, 2017-04, Vol.49 (4), p.416-421

2017

Link zum Volltext

Verfügbarkeit prüfen

High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center

Clinical infectious diseases, 2016-10, Vol.63 (7), p.954-958

2016

Link zum Volltext

Verfügbarkeit prüfen

Challenges in the Treatment of Infections Caused by Gram-Positive and Gram-Negative Bacteria in Patients with Cancer and Neutropenia

Clinical infectious diseases, 2005-04, Vol.40 (Supplement-4), p.S246-S252

Rolston, Kenneth V I

2005

Link zum Volltext

Verfügbarkeit prüfen

Candidemia in Patients With Hematologic Malignancies in the Era of New Antifungal Agents (2001-2007): Stable Incidence But Changing Epidemiology of a Still Frequently Lethal Infection

Cancer, 2009-10, Vol.115 (20), p.4745-4752

2009

Link zum Volltext

Verfügbarkeit prüfen

Zygomycosis in the 1990s in a Tertiary-Care Cancer Center

Clinical infectious diseases, 2000-06, Vol.30 (6), p.851-856

2000

Link zum Volltext

Verfügbarkeit prüfen

Infections with the agent of ‘kennel cough’ in patients with cancer

The Journal of infection, 2019-01, Vol.78 (1), p.48-53

2019

Link zum Volltext

Verfügbarkeit prüfen

Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center

American journal of infection control, 2014-10, Vol.42 (10), p.1084-1088

2014

Link zum Volltext

Verfügbarkeit prüfen

Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization

Journal of antimicrobial chemotherapy, 2010-09, Vol.65 (9), p.2001-2004

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 254

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(215)

Publikationsform

Artikel
(253)
Buchkapitel
(1)

Sprache

Englisch
(254)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(215)
Life Sciences & Biomedicine
(214)
Male
(122)
Biological And Medical Sciences
(120)
Medical Sciences
(119)
Female
(118)
Middle Aged
(105)
Adult
(103)
Infectious Diseases
(97)
Neoplasms - Complications
(87)
Aged
(83)
Microbiology
(80)
Oncology
(68)
Pharmacology. Drug Treatments
(60)
Anti-Bacterial Agents - Therapeutic Use
(56)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(53)
Microbial Sensitivity Tests
(52)
Antibacterial Agents
(50)
Retrospective Studies
(47)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline

Neutropenic Enterocolitis, a Growing Concern in the Era of Widespread Use of Aggressive Chemotherapy

The current spectrum of infection in cancer patients with chemotherapy related neutropenia

Activity of Cefiderocol and Comparators against Isolates from Cancer Patients

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

Administering an additional hepatitis B vaccination dose after 18 years maintains adequate long-term protection levels in healthcare workers

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update

Postobstructive Pneumonia in Cancer Patients

2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

Polymicrobial Infection in Patients with Cancer: An Underappreciated and Underreported Entity

The impact of incorporating early rapid influenza diagnosis on hospital occupancy and hospital acquired influenza

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

Stenotrophomonas maltophilia: Changing Spectrum of a Serious Bacterial Pathogen in Patients with Cancer

Development and Validation of a Clinical Model to Predict the Presence of β-Lactam Resistance in Viridans Group Streptococci Causing Bacteremia in Neutropenic Cancer Patients

The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC “Neutropenia, Infection and Myelosuppression” Study Group during the MASCC annual meeting held in Berlin on 27–29 June 2013

Viridans Streptococci Isolated by Culture from Blood of Cancer Patients: Clinical and Microbiologic Analysis of 50 Cases

Daptomycin use in neutropenic patients with documented gram-positive infections

In vitro activity of ceftaroline and comparator agents against Gram-positive and Gram-negative clinical isolates from cancer patients

High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center

Challenges in the Treatment of Infections Caused by Gram-Positive and Gram-Negative Bacteria in Patients with Cancer and Neutropenia

Candidemia in Patients With Hematologic Malignancies in the Era of New Antifungal Agents (2001-2007): Stable Incidence But Changing Epidemiology of a Still Frequently Lethal Infection

Zygomycosis in the 1990s in a Tertiary-Care Cancer Center

Infections with the agent of ‘kennel cough’ in patients with cancer

Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center

Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization

Aktive Filter

Suchergebnisse filtern